Insulet (PODD) Change in Account Payables (2020 - 2026)
Insulet (PODD) posted Change in Account Payables of $71.4 million for Q1 2026, up 202.54% on a QoQ basis from $23.6 million in Q4 2025, and up 95.62% year-over-year from $36.5 million in Q1 2025.
Insulet (PODD) Change in Account Payables (2020 - 2026) Analysis & Trends
Insulet's Change in Account Payables history runs 7 years deep, the most recent figure standing at $71.4 million for Q1 2026.
- Quarterly Change in Account Payables rose 95.62% year-over-year to $71.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.1 million (up 600.6% YoY) and the FY2025 annual result came in at $49.2 million, up 2136.36% from the prior year.
- Change in Account Payables was $71.4 million for Q1 2026 at Insulet, up from $23.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $71.4 million in Q1 2026 and bottomed at -$52.5 million in Q4 2023.
- A 5-year average of $6.4 million and a median of $5.4 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables plunged 1131.25% — and 2025, when it soared 3911.11%.
- Insulet's Change in Account Payables stood at -$25.7 million in 2022, then tumbled by 104.28% to -$52.5 million in 2023, then soared by 66.1% to -$17.8 million in 2024, then soared by 232.58% to $23.6 million in 2025, then surged by 202.54% to $71.4 million in 2026.
- Business Quant data shows PODD's Change in Account Payables at $71.4 million in Q1 2026, $23.6 million in Q4 2025, and -$47.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 71.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.40 Mn |
| Mar 31, 2026 | 71.40 Mn |
| Dec 31, 2025 | 23.60 Mn |
| Dec 31, 2025 | 23.60 Mn |
| Sep 30, 2025 | -47.00 Mn |
| Sep 30, 2025 | -47.00 Mn |
| Jun 30, 2025 | 36.10 Mn |
| Jun 30, 2025 | 36.10 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Dec 31, 2024 | -17.80 Mn |
| Dec 31, 2024 | -17.80 Mn |
| Sep 30, 2024 | -36.40 Mn |
| Sep 30, 2024 | -36.40 Mn |
| Jun 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 55.50 Mn |
| Mar 31, 2024 | 55.50 Mn |
| Dec 31, 2023 | -52.50 Mn |
| Dec 31, 2023 | -52.50 Mn |